← Back to Search

Intervention-specific Carevive questionnaire for Shared Decision Making

N/A

Waitlist Available

Led By Gabrielle B Rocque, MD

Research Sponsored by University of Alabama at Birmingham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 years

Awards & highlights

Study Summary

This trial is to test whether giving patients information about their treatment options at the time of decision-making (SDM) leads to them feeling like they had a greater role in decision-making, compared to standard oncology care where treatment plans are given after decisions have already been made.

Eligible Conditions

Shared Decision Making

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Impact of Shared Decision Making

Trial Design

2Treatment groups

Experimental Treatment

Group I: Standard of Care QuestionnaireExperimental Treatment1 Intervention

Patients randomized to standard of care will receive the standard-of-care Carevive questionnaire used to generate TPs at time of enrollment and then every 6 months for patients with MBC who have not made a treatment decision until a treatment decision is made. One month or at the next visit following the decision, the patient will be asked to complete a post-treatment survey using REDCap.

Group II: Shared Decision Making QuestionnaireExperimental Treatment1 Intervention

Patients randomized to the intervention arm will receive the intervention-specific Carevive questionnaire, which includes standard questions with additional decision-making questions. These surveys will be repeated every 6 months until the patient has received a TP. One month or at the next visit following the decision, the patient will be asked to complete a research survey using REDCap.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Carevive Systems, Inc.Industry Sponsor

15 Previous Clinical Trials

914 Total Patients Enrolled

University of Alabama at BirminghamLead Sponsor

1,590 Previous Clinical Trials

2,281,214 Total Patients Enrolled

2 Trials studying Shared Decision Making

328 Patients Enrolled for Shared Decision Making

American Cancer Society, Inc.OTHER

224 Previous Clinical Trials

110,315 Total Patients Enrolled

1 Trials studying Shared Decision Making

200 Patients Enrolled for Shared Decision Making

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have been accepted into this medical research project?

"Affirmative. According to the information available on clinicaltrials.gov, this research is actively looking for test subjects since it was first posted on December 11th 2018 with an update of May 4th 2022. 140 people must be recruited from 1 medical location."

Answered by AI

Are there still vacancies for individuals who wish to participate in this experiment?

"According to current information on clinicaltrials.gov, this study is actively welcoming participants. It was first published in December of 2018 and has been recently updated as of May 4th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Enhancing Shared Decision-Making in Breast Cancer

Gabrielle Rocque 2018. "Enhancing Shared Decision-Making in Breast Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03806738.